ALT5 Sigma (ALTS) Competitors

ALT5 Sigma (NASDAQ:ALTS) and aTyr Pharma (NASDAQ:ATYR) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

Which has better valuation & earnings, ALTS or ATYR?

ALT5 Sigma has higher revenue and earnings than aTyr Pharma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ALT5 Sigma	$18.05M	6.87	-$6.24M	N/A	N/A
aTyr Pharma	$230K	2,147.61	-$64.02M	-$0.81	-6.85

Do analysts prefer ALTS or ATYR?

aTyr Pharma has a consensus target price of $20.20, indicating a potential upside of 263.96%. Given aTyr Pharma's stronger consensus rating and higher possible upside, analysts clearly believe aTyr Pharma is more favorable than ALT5 Sigma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ALT5 Sigma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
aTyr Pharma	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.14

Does the media prefer ALTS or ATYR?

In the previous week, aTyr Pharma had 6 more articles in the media than ALT5 Sigma. MarketBeat recorded 8 mentions for aTyr Pharma and 2 mentions for ALT5 Sigma. ALT5 Sigma's average media sentiment score of 0.63 beat aTyr Pharma's score of 0.59 indicating that ALT5 Sigma is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ALT5 Sigma	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
aTyr Pharma	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, ALTS or ATYR?

ALT5 Sigma has a beta of 2.21, suggesting that its stock price is 121% more volatile than the S&P 500. Comparatively, aTyr Pharma has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in ALTS or ATYR?

6.3% of ALT5 Sigma shares are held by institutional investors. Comparatively, 61.7% of aTyr Pharma shares are held by institutional investors. 4.9% of ALT5 Sigma shares are held by insiders. Comparatively, 3.7% of aTyr Pharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Is ALTS or ATYR more profitable?

aTyr Pharma has a net margin of 0.00% compared to ALT5 Sigma's net margin of -38.58%. aTyr Pharma's return on equity of -87.09% beat ALT5 Sigma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ALT5 Sigma	-38.58%	-113.79%	-8.96%
aTyr Pharma	N/A	-87.09%	-64.77%

Summary

aTyr Pharma beats ALT5 Sigma on 9 of the 15 factors compared between the two stocks.